Recipelist

News

  1. Increase in Dutch VAT Rate on (supplementary) animal feed from January 1st 2025

    Complementary feed for horses

    Effective January 1st 2025, the VAT rate on a wide range of animal feed and related products will increase from 9% to 21%, as determined by the Dutch Tax Office. This adjustment applies to all complementary feeds, including but not limited to feed supplements, dietary feeds, rearing milk, vitamins, minerals, and other feed additives. Consequently, Grovet is required to implement the new 21% VAT rate for all deliveries made on or after this date.

    It is recommended that invoicing processes be updated accordingly to ensure compliance.

    For further details, please consult the official notice issued by the Dutch Tax Office

    Read more »
  2. Big Little Fats; benefits of Omega-3 fatty acids in the Horse

    Omega-3 fatty acids for a healthy horse

    While nutrition has historically been considered the appropriate amount of nutrients needed for energy, to maintain weight and promote growth, the majority of dietary effects may actually occur in ways that are, in fact, not always obvious to the naked eye. This is until there is evidence of a health concern. But what is consumed through the daily diet really begins by influencing at the level of the cell and has a profound effect on each and every living animal. What the horse consumes has the ability to benefit so many areas of health, including immunity, athletic performance, reproduction, metabolism, longevity and more. But what the horse takes in daily also has the ability to interfere or take away from the health and well-being of the animal. A specific fat, the omega-3 fatty acid, has a significant role in equine nutrition due to its multiple applications on numerous health

    Read more »
  3. HorStem; world’s first drug based on equine umbilical cord mesenchymal stem cells

    HorStem; world’s first drug based on equine umbilical cord mesenchymal stem cells

    HorStem is the first registered veterinary medicine based on mesenchymal stem cells obtained from the umbilical cord of horses. Stem cells reduce lameness in horses with mild to moderate degenerative joint disease (OA).

    It is a ready-to-use, sterile, injectable suspension for intra-articular use in horses. Each vial contains 15 million active stem cells, more than enough to achieve the minimum effective dose in the joint regardless of the degree of inflammation or the patient's immune system status.

    How does HorStem work?

    The mechanism of action of HorStem is illustrated in the figure on the right. Mesenchymal stem cells are activated in the synovium by inflammatory cytokines. In response, they secrete anti-inflammatory cytokines such as Prostaglandin E2 (PGE2).

    While PGE2 is primarily known for its pro-inflammatory effects, it also plays a crucial role in regulating inflammation. It is one of the major immunomodulatory cytokines in the body.

    When applied to horses with OA, HorStem inhibits T-cell proliferation, reduces the production of pro-inflammatory cytokines like TNF-alpha, and decreases the presence of matrix metalloproteinases (MMPs) that contribute to the breakdown of cartilage's extracellular matrix. Studies have shown that these effects are mediated by PGE2. (1)

    Moreover, umbilical cord-derived mesenchymal stem cells stimulate the production of anti-inflammatory cytokines such as IL-4, IL-5, IL-10, and TGF-beta. As the inflammatory response ceases

    Read more »
  4. Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe

    Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe

    Expansion adds new countries to Grovet's existing PulseVet distribution coverage and enables launch of the TRUFORMA® equine platform in Europe

    ANN ARBOR, MI / ACCESSWIRE / October 3, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the expansion of its distribution partnership in Europe with Grovet, a leading equine-focused veterinary distributor.

    The terms of the updated agreement offer Grovet equine distribution rights for Zomedica's equine PulseVet® and TRUFORMA product platforms throughout most of Europe. Grovet will exclusively distribute these equine products in 27 countries, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary,

    Read more »
  5. Meet our team at...

    Meet our team at...

    Meet our team at...

    Oct. 10 to 11

    ESER - BE

    Oct. 24 to 25

    ISELP - FR

    Oct. 26 to 27

    Expovet - BE

    31 oktober t/m 2 november

    Sports Medicine and Rehabilitation Days - NL


    We look forward to meeting you!

    Read more »
  6. Advanced orthopedic care and rehabilitation for horses: discover Paniolo and IceHorse

    Ice-Horse & Paniolo products

    At Grovet, you will find a wide range of innovative products for the prevention and rehabilitation of injuries for horses. In this blog, we would like to introduce you to Paniolo and IceHorse, unique brands that contribute to the health of horses.

    Read more »
  7. The difference between Pro-Stride APS, Restigen PRP and CenTrate

    The difference between Pro-Stride APS, Restigen PRP and CenTrate

    What is the Pro-Stride system?


    Pro-Stride, Restigen and Centrate are medical devices that allow blood from horses to be processed into solutions that can be used for therapy. Autologous protein solution (APS), PRP and concentrates from bone marrow aspirate can be prepared in less than 30 minutes. The system is suitable for outpatient use and incubation is not required. The closed system makes it a safe procedure with minimal risk of contamination. 

    Platelet-rich plasma, Restigen PRP

    Restigen PRP is used primarily for tendon

    Read more »
  8. Meet our team at...

    Meet our team at...

    Meet our Grovet team at...

    Aug. 15 to 17

    ISELP - DE

    Sept. 6 to 7

    VetPD - DE

    Sept. 11 to 14

    BEVA - UK

    Sept. 17 to 20 

    ISELP - NL 

     

    We are looking forward to meeting you!

    Read more »
  9. High-energy, focused shock wave technology with PulseVet

    High-energy, focused shock wave technology with PulseVet

    For many years, the technology of PulseVet and its predecessor VersaTron, has been used successfully in the treatment of horses. The therapy has proven effective in several clinical trials to treat many indications, including wounds, tendon injuries, back pain and fractures.

    The PulseVet technology 

    PulseVet uses electrohydraulic sound waves, these focused and high-energy shock waves can reach deep tissue. Locally, these waves trigger a tissue reaction. Multiple proteins, osteogenic and angiogenic growth factors and anti-inflammatory cytokines are released in the tissue. Bone and tissue growth are stimulated. In addition, the formation of new blood vessels leads to increased local blood flow. These processes inhibit inflammation and promote recovery.

    The PulseVet device 

    The PulseVet

    Read more »
  10. Grovet's supplements to support the management of (sport) horses

    Grovet's supplements to support the management of (sport) horses

    At Grovet, we are driven to exceed equine veterinarian expectations and are constantly developing our product line to continue to optimize it. Our supplements for horses are of high quality and are formulated based on scientific evidence. Grovet offers a wide range of complementary feeds to support the management of sport horses, read more below. 

    Our all-in-one supplement Artilium Complete with improved formula

    Read more »
Page
© 2024 Grovet B.V. All rights reserved.